ICC LABS INC. REGISTERED SHARES O.N. WKN: A2JAMF ISIN: CA4492341033 Kürzel: 2Q9 Forum: Aktien Thema: Hauptdiskussion

1,113 EUR
-0,43 %-0,005
3. Dec, 21:41:29 Uhr, Lang & Schwarz
Kommentare 61
D
Datenspezialist, 29.03.2018 0:12 Uhr
0
Gute News heute. Ich halte an den 2 CAD noch fest und kaufe nach.
g
gerd_mödlhauser, 28.03.2018 17:48 Uhr
0
Schaut leider nicht danach aus..
D
Datenspezialist, 20.03.2018 17:43 Uhr
0
Im April sollten wir über 2 Dollar stehen
n
new_investor, 16.03.2018 18:09 Uhr
0
Spätestens bis Sommer haben wir Kurse von 3-5 cad
J
Josef_Meindl, 15.03.2018 18:20 Uhr
0
Bin gespannt wann’s hier so richtig nach oben schießt!
n
new_investor, 12.03.2018 14:25 Uhr
0
http://www.beprofiteer.com/nlhtm/show.php?id=252
n
new_investor, 12.03.2018 14:25 Uhr
0
ICC Labs - Produktionskosten von 8 Cent pro Gramm Cannabis
D
Datenspezialist, 08.03.2018 20:22 Uhr
0
steigende Verkaufspreise in Uruguay, Erhöhung der Produktion - alles läuft nach Plan
D
Datenspezialist, 08.03.2018 20:22 Uhr
0
@MYM - nichts wieso?
n
new_investor, 07.03.2018 15:06 Uhr
0
ICC Labs Provides Operational Update on Recreational Cannabis Business Highlights: A flowering room in ICC Labs’ 70,565 sq. ft. greenhouse in San José, Uruguay. 24,179 plants in stock as of March 1st, 2018. The regulatory authorities applied new specifications to the packages because of the new levels of cannabinoids. The Company has reached aggregate production of 1,000 kilograms of dried recreational cannabis. In January 2018, the Government of Uruguay increased the domestic sale price for recreational cannabis by 6.5%. New levels of THC (tetrahydrocannabinol) and CBD (cannabidiol) in dried recreational cannabis are now permitted for sale, THC ≤ 9% and CBD ≥ 3%, specifically. VANCOUVER, British Columbia, March 07, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) is pleased to provide an operational update with respect to its recreational cannabis business in Uruguay. ICC Labs continues to work with Ministry of Health, IRCCA (Cannabis Regulation and Control Institute) and other partners to improve its production capacity in order to meet Uruguay’s growing domestic demand for recreational cannabis. Recreational Cannabis Production Update Since July 19, 2017, ICC Labs has sold 66,512 packages of recreational cannabis consisting of five grams per package through licensed pharmacies approved by the Ministry of Health and IRCCA. To date, the Company has produced more than 1,000 kilograms of recreational cannabis for the Uruguayan domestic market. Continued increases in Uruguayan Registered Users The Uruguayan recreational cannabis registry registered 17,377 new users from July 19, 2017 to March 4th, 2018, bringing total active registered users to 21,877. The Company also expects authorizations for additional points of sale at new pharmacies seeking sales licenses, which should be supportive to the registered user base. Due to the increase in the number of registered users in the recreational cannabis registry over the last seven months, and the resulting expected increase in demand, the Company has informed IRCCA of the Company’s increased annual production target for dried recreational cannabis from two tonnes per year to five tonnes per year. Sales for the additional three tonnes of cannabis are subject to approval from IRCCA. The Company expects its existing greenhouse facility in San José, Uruguay, which is comprised of more than 70,000 square foot of production space, to be able to accommodate the increased production quota. Approval of New THC and CBD Levels and Pricing The Company is also pleased to announce the approval by IRCCA and Ministry of Health of new levels of recreational cannabis with THC ≤ 9% and CBD ≥ 3%. In addition to these new levels, IRCCA has approved an increase in the sales price for dried recreational cannabis of 6.5% to U.S.$ 1.41 per gram effective January 2018. Commitment to Production Quality While the Company is increasing production volumes, it continues to emphasize its products’ quality. The Company continues to focus on pharmaceutical grade standards with all products registered under the Ministry of Health. “We continue to advance our business plan methodically, adjusting continuously to reflect the rapidly changing environment in this sector. We are very proud of the great efforts put forth by our entire team so far and remain committed to delivering on the potential of ICC Labs," commented Alejandro Antalich, Chief Executive Officer of ICC Labs.
n
new_investor, 07.03.2018 15:05 Uhr
0
News!!!
MYMaerta
MYMaerta, 07.03.2018 10:59 Uhr
0
Was haben die mit EMERALD zu tun ? Dankeschön!!!
F
FritzTheCat, 06.03.2018 17:00 Uhr
0
Will einfach nicht über 1,50 CAD springen
D
Datenspezialist, 02.03.2018 20:15 Uhr
0
ja, muss man haben. habe gut eingesammelt. jetzt kann es hochgehen.
n
new_investor, 01.03.2018 11:39 Uhr
0
Die ersten Analysten informieren das die Korrektur bei den cannabiswerten vorbei ist..... Beacon Securities predict a "broad based" rally
n
new_investor, 01.03.2018 11:37 Uhr
0
Nach dem News von vorgestern .....
Meistdiskutiert
Thema
1 Jaguar Health für Investierte und Interessierte ±0,00 %
2 GAMESTOP Hauptdiskussion -20,31 %
3 Trading- und Aktien-Chat
4 PLUG POWER Hauptdiskussion +0,07 %
5 Tempest Therapeutics Hauptdiskussion ±0,00 %
6 AMC ENTERTAINMENT Hauptdiskussion -5,38 %
7 FREYR BATTERY -1,60 %
8 REALTY INCOME Hauptdiskussion -0,04 %
9 Novavax Hauptdiskussion -0,03 %
10 TUPPERWARE Hauptdiskussion +0,03 %
Alle Diskussionen
Anzeige Über 2000 Sparpläne auf Aktien, ETFs und Fonds ab 0 Euro - Jetzt entdecken
Aktien
Thema
1 Jaguar Health für Investierte und Interessierte ±0,00 %
2 GAMESTOP Hauptdiskussion -19,62 %
3 PLUG POWER Hauptdiskussion +0,07 %
4 Tempest Therapeutics Hauptdiskussion ±0,00 %
5 AMC ENTERTAINMENT Hauptdiskussion -4,75 %
6 FREYR BATTERY -1,60 %
7 REALTY INCOME Hauptdiskussion -0,04 %
8 Novavax Hauptdiskussion -0,03 %
9 BioNTech Hauptdiskussion +0,51 %
10 EcoGraf Hauptdiskussion ±0,00 %
Alle Diskussionen